Serum-free differentiation of functional human coronary-like vascular smooth muscle cells from embryonic stem cells

Cardiovascular Research

Volumn 98, Issue 1, 2013, Pages 125-135

  El Mounayri, Omar ^a,b,c,d   Mihic, Anton ^a,b,c,d   Shikatani, Eric A ^a,b,c,d   Gagliardi, Mark ^a   Steinbach, Sarah K ^a,b,d   Dubois, Nicole ^a   Dacosta, Ralph ^c,e   Li, Ren Ke ^a,b,c,d   Keller, Gordon ^a   Husain, Mansoor ^a,b,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Coronary smooth muscle cell; Human embryonic stem cell; Smooth muscle differentiation; Vascular endothelial growth factor

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

ACTINS; ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; CORONARY VESSELS; CULTURE MEDIA, SERUM-FREE; EMBRYONIC STEM CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MICE, SCID; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOCONSTRICTION;

EID: 84875128533     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs357     Document Type: Article

References (42)

1. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007;27:1248-1258.
2. Waldo KL, Hutson MR, Ward CC, Zdanowicz M, Stadt HA, Kumiski D et al. Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev Biol 2005;281:78-90.
3. Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM. Fate of the mammalian cardiac neural crest. Development 2000;127:1607-1616.
4. Kolodziejska KM, Noyan-Ashraf MH, Nagy A, Bacon A, Frampton J, Xin HB et al. c-Myb-dependent smooth muscle cell differentiation. Circ Res 2008;102:554-561.
5. Ishida M, El-Mounayri O, Kattman S, Zandstra P, Sakamoto H, Ogawa M et al. Regulated expression and role of c-Myb in the cardiovascular-directed differentiation of mouse embryonic stem cells. Circ Res 2012;110:253-264.
6. Mann KM, Ray JL, Moon ES, Sass KM, Benson MR. Calcineurin initiates smooth muscle differentiation in neural crest stem cells. J Cell Biol 2004;165:483-491.
7. Jain MK, Layne MD, Watanabe M, Chin MT, Feinberg MW, Sibinga NE et al. In vitro system for differentiating pluripotent neural crest cells into smooth muscle cells. J Biol Chem 1998;273:5993-5996.
8. Steinbach SK, El-Mounayri O, Dacosta RS, Frontini MJ, Nong Z, Maeda A et al. Directed differentiation of skin-derived precursors into functional vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011;31:2938-2948.
9. Rodriguez LV, Alfonso Z, Zhang R, Leung J, Wu B, Ignarro LJ. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A 2006;103:12167-12172.
10. Kashiwakura Y, Katoh Y, Tamayose K, Konishi H, Takaya N, Yuhara S et al. Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow. Circulation 2003;107:2078-2081.
11. Gong Z, Niklason LE. Use of human mesenchymal stem cells as alternative source of smooth muscle cells in vessel engineering. Methods Mol Biol 2011;698:279-294.
12. Ross JJ, Hong Z, Willenbring B, Zeng L, Isenberg B, Lee EH et al. Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest 2006;116:3139-3149.
13. Le Ricousse-Roussanne S, Barateau V, Contreres JO, Boval B, Kraus-Berthier L, Tobelem G. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 2004;62:176-184.
14. Huang H, Zhao X, Chen L, Xu C, Yao X, Lu Y et al. Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun 2006;351:321-327.
15. Hill KL, Obrtlikova P, Alvarez DF, King JA, Keirstead SA, Allred JR et al. Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol 2010;38:246-257.e1.
16. Matsubayashi K, Fedak PW, Mickle DA, Weisel RD, Ozawa T, Li RK. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 2003;108(Suppl. 1):II219-25.
17. Oberpenning F, Meng J, Yoo JJ, Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 1999;17:149-155.
18. Staudacher DL, Preis M, Lewis BS, Grossman PM, Flugelman MY. Cellular and molecular therapeutic modalities for arterial obstructive syndromes. Pharmacol Ther 2006; 109:263-273.
19. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001;233: 88-96.
20. Lawson JH, Lynn KA, Vanmatre RM, Domzalski T, Klemp KF, Ortel TL et al. Antihuman factor V antibodies after use of relatively pure bovine thrombin. Ann Thorac Surg 2005;79:1037-1038.
21. Topouzis S, Majesky MW. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev Biol 1996;178:430-445.
22. Gadson PF Jr, Dalton ML, Patterson E, Svoboda DD, Hutchinson L, Schram D et al. Differential response of mesoderm- and neural crest-derived smooth muscle to TGF-beta1: regulation of c-myb and alpha1 (I) procollagen genes. Exp Cell Res 1997;230:169-180.
23. Cheung C, Bernardo AS, Trotter MW, Pedersen RA, Sinha S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol 2012;30:165-173.
24. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A et al. Stagespecific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011;8:228-240.
25. Dubois NC, Craft AM, Sharma P, Elliott DA, Stanley EG, Elefanty AG et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 2011;29:1011-1018.
26. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
27. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell- derived population. Nature 2008;453:524-528.
28. Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A et al. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol 2007;27:2127-2134.
29. Korff T, Augustin HG. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 1998;143:1341-1352.
30. Sckell A, Leunig M. Dorsal skinfold chamber preparation in mice: studying angiogenesis by intravital microscopy. Methods Mol Med 2001;46:95-105.
31. Marvin MJ, Di Rocco G, Gardiner A, Bush SM, Lassar AB. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 2001;15:316-327.
32. Mima T, Ueno H, Fischman DA, Williams LT, Mikawa T. Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci U S A 1995;92:467-471.
33. Schneider VA, Mercola M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev 2001;15:304-315.
34. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995;9: 2105-2116.
35. Kuro-o M, Nagai R, Nakahara K, Katoh H, Tsai RC, Tsuchimochi H et al. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 1991;266: 3768-3773.
36. Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993;73:1000-1012.
37. Frangogiannis NG, Michael LH, Entman ML. Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res 2000;48:89-100.
38. Ruzicka DL, Schwartz RJ. Sequential activation of alpha-actin genes during avian cardiogenesis: vascular smooth muscle alpha-actin gene transcripts mark the onset of cardiomyocyte differentiation. J Cell Biol 1988;107:2575-2586.
39. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 2001;188:359-368.
40. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev 1979;59:1-61.
41. Hermant B, Desroches-Castan A, Dubessay ML, Prandini MH, Huber P, Vittet D. Development of a one-step embryonic stem cell-based assay for the screening of sprouting angiogenesis. BMC Biotechnol 2007;7:20.
42. Vandekerckhove J, Bugaisky G, Buckingham M. Simultaneous expression of skeletal muscle and heart actin proteins in various striated muscle tissues and cells. A quantitative determination of the two actin isoforms. J Biol Chem 1986;261:1838-1843.